Cancer glossary
Docetaxel: which cancers it treats and which side effects to expect
Docetaxel is a chemotherapy drug from the taxane group. Schedules, use in breast, prostate, stomach and lung cancer, fluid retention, neutropenia and nail changes.
Written and medically reviewed by
Dr. Tara EinullaevaMedical oncologist, 9 years in practice. Credentials · reviewed 19 October 2026
In short
Docetaxel is a chemotherapy drug from the taxane group, a relative of paclitaxel. It stops the cell dividing by blocking microtubules.
How it appears in your prescription
- ‘Docetaxel 75 mg/m² every 3 weeks’.
- ‘TCH / docetaxel + trastuzumab + pertuzumab’ — in HER2-positive breast cancer.
- ‘FLOT’ — docetaxel, oxaliplatin, fluorouracil, leucovorin — before and after surgery for stomach cancer.
- ‘Docetaxel + prednisone’ — in prostate cancer.
What it means
According to the US National Cancer Institute, docetaxel is approved for breast cancer, non-small cell lung cancer, prostate, stomach, and head and neck cancer. The schedule and combinations depend on the tumor type and stage.
Side effects
Low neutrophils with a risk of febrile neutropenia, hair loss, fluid retention and swelling, nail changes (darkening, lifting), mouth sores, fatigue and neuropathy. Sometimes G-CSF is given as prevention.
Call your doctor urgently with a temperature of 38 °C (100.4 °F) or higher, or rapidly increasing swelling or breathlessness.
Questions to ask your doctor
- Do I need G-CSF prevention?
- How should I take dexamethasone around the infusion?
- How can I protect my nails (cooling, nail varnish) during treatment?
Sources
- Docetaxel — National Cancer Institute
- WBC Growth Factors: ASCO Guideline Update — ASCO
- Drugs Approved for Stomach (Gastric) Cancer — National Cancer Institute
FAQ
Related terms
This is reference information and not a substitute for medical advice. Your doctor interprets each value in the context of your whole situation.
